These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3069961)

  • 1. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease.
    Connolly JH; Allen IV; Dermott E
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1459-60. PubMed ID: 3069961
    [No Abstract]   [Full Text] [Related]  

  • 2. Creutzfeldt-Jakob disease. Failure to detect spiroplasmas by cultivation and serological tests.
    Leach RH; Matthews WB; Will R
    J Neurol Sci; 1983 Jun; 59(3):349-53. PubMed ID: 6348215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiroplasma-like inclusions in Creutzfeldt-Jakob disease.
    Bastian FO
    Arch Pathol Lab Med; 1979 Dec; 103(13):665-9. PubMed ID: 389196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease, spiroplasmas, and crystalline artifacts.
    Humphery-Smith I; Chastel C
    Lancet; 1988 Nov; 2(8621):1199. PubMed ID: 2903412
    [No Abstract]   [Full Text] [Related]  

  • 5. Additional evidence of spiroplasma in Creutzfeldt-Jakob disease.
    Bastian FO; Hart MN; Cancilla PA
    Lancet; 1981 Mar; 1(8221):660. PubMed ID: 6110879
    [No Abstract]   [Full Text] [Related]  

  • 6. Spiroplasma and Creutzfeldt-Jakob disease.
    Gray A; Francis RJ; Scholtz CL
    Lancet; 1980 Jul; 2(8186):152. PubMed ID: 6105326
    [No Abstract]   [Full Text] [Related]  

  • 7. Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease.
    Salazar AM; Masters CL; Gajdusek DC; Gibbs CJ
    Ann Neurol; 1983 Jul; 14(1):17-26. PubMed ID: 6351721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Creutzfeldt-Jakob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.
    Bastian FO
    J Alzheimers Dis; 2017; 56(3):867-873. PubMed ID: 28059790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease: procedures for handling diagnostic and research materials.
    Bastian FO; Jennings RA
    Infect Control; 1984 Jan; 5(1):48-50. PubMed ID: 6358089
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to: Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report.
    Hayashi Y; Inuzuka T
    J Neurol Sci; 2017 Apr; 375():489. PubMed ID: 28258726
    [No Abstract]   [Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease with demonstration of virus-like particles.
    Shibayama Y; Sakaguchi Y; Nakata K; Goto T; Nakai M; Takai T; Shirakata S
    Acta Pathol Jpn; 1982 Jul; 32(4):695-702. PubMed ID: 7051752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: The Letter to be published with the Letter, Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report.
    Yaguchi H; Takeuchi A; Horiuchi K; Takahashi I; Shirai S; Akimoto S; Satoh K; Moriwaka F; Yabe I; Sasaki H
    J Neurol Sci; 2017 Apr; 375():490-491. PubMed ID: 28259353
    [No Abstract]   [Full Text] [Related]  

  • 16. Membrane filtration and the Creutzfeldt-Jakob agent.
    Taylor DM
    Lancet; 1985 Dec 21-28; 2(8469-70):1430-1. PubMed ID: 2867425
    [No Abstract]   [Full Text] [Related]  

  • 17. A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease.
    Mori S; Hamada C; Kumanishi T; Fukuhara N; Ichihashi Y; Ikuta F; Miyatake T; Tsubaki T
    Neurology; 1989 Oct; 39(10):1337-42. PubMed ID: 2677833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report.
    Yaguchi H; Takeuchi A; Horiuchi K; Takahashi I; Shirai S; Akimoto S; Satoh K; Moriwaka F; Yabe I; Sasaki H
    J Neurol Sci; 2017 Jan; 372():444-446. PubMed ID: 27838004
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity.
    Taylor DM
    Neuropathol Appl Neurobiol; 1989; 15(6):585-6. PubMed ID: 2693993
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.